Nurse-Delivered Brief Behavioral Treatment for Insomnia in Lung Cancer Survivors: A Pilot RCT

Autor: Carleara Weiss, Joseph F Lucke, Grace E. Dean, Carla R. Jungquist, Rana Alameri, Samjot Singh Dhillon, Lynn M. Steinbrenner, Michelle L. Klimpt, Suzanne S. Dickerson, Elisabeth U. Dexter, Patricia Ziegler
Rok vydání: 2019
Předmět:
Male
medicine.medical_specialty
Lung Neoplasms
medicine.medical_treatment
Neuroscience (miscellaneous)
MEDLINE
Medicine (miscellaneous)
Pilot Projects
Article
law.invention
03 medical and health sciences
0302 clinical medicine
Randomized controlled trial
Cancer Survivors
law
Sleep Initiation and Maintenance Disorders
Surveys and Questionnaires
mental disorders
Insomnia
medicine
Humans
Lung cancer
Aged
Aged
80 and over
Cognitive Behavioral Therapy
business.industry
Standard treatment
Behavioral treatment
Middle Aged
medicine.disease
humanities
nervous system diseases
Cognitive behavioral therapy
Treatment Outcome
030228 respiratory system
Physical therapy
Quality of Life
Female
Neurology (clinical)
Psychology (miscellaneous)
medicine.symptom
business
human activities
030217 neurology & neurosurgery
Zdroj: Behav Sleep Med
ISSN: 1540-2010
Popis: OBJECTIVE/BACKGROUND: Insomnia occurs in 50 to 80% of lung cancer survivors. Cognitive behavioral therapy is the standard treatment for insomnia (CBTI); however, treatment length and lack of psychologists trained in CBTI limits access. Brief Behavioral Treatment for Insomnia (BBTI), a nurse-delivered modified CBTI, is proposed. This feasibility pilot study sought to compare the BBTI intervention to attention control Healthy Eating Program (HEP) for insomnia in lung cancer survivors. PARTICIPANTS: The participants comprised adults, 21 years of age or older with insomnia and stage I/II non-small cell lung cancer, more than 6 weeks from surgery and living in Western NY. METHODS: Participants (n=40) were randomly assigned to an experimental (BBTI) or attention control condition (Healthy Eating Program). Thirty participants completed the study. RESULTS: Participants were 66 years of age (± 7.6; range 53–82), 40% (n=16) male, 87.5% (n=35) Caucasian, 50% (n=20) married, BMI 27.7 (± 5.8), and 12% (n=5) never smokers. Baseline sleep diary sleep efficiency, ISI and other baseline covariates were balanced between the groups. Sleep efficiency improved ≥85% in BBTI group (p=.02), but not in HEP control group (p=1.00). Mean ISI for BBTI and attention control were 6.40 ± 4.98 and 14.10 ± 4.48 (p=.001) respectively. In addition, BBTI group mean total FACT-L score improved by 6.66 points from baseline while HEP group score worsened (p=0.049). CONCLUSIONS: BBTI is a practical, evidence-based, clinically relevant intervention that improved sleep and quality of life in lung cancer survivors with insomnia. Additional research to evaluate efficacy, duration, and implementation strategies are essential.
Databáze: OpenAIRE
Externí odkaz: